TransMedics Group (TMDX) PT Lowered to $75 at Stifel
Stifel analyst Thomas Stephan lowered the price target on TransMedics Group (NASDAQ: TMDX) to $75.00 (from $85.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
